Significats de subcutaneous administration en anglès

Objectives: This report demonstrates a singular case of subcutaneous administration of n-hexane.

On this condition, subcutaneous administration of PPG or HA reduced tactile allodynia in diabetic rats.

Although there are excellent long-term data for intravenous application, similar data regarding subcutaneous administration are lacking.

Conclusion: The population pharmacokinetic analysis confirmed that etanercept is slowly absorbed and eliminated after subcutaneous administration.

Background: Intravenous injection is the standard administration route of bortezomib; however, subcutaneous administration is an important alternative.

Anaemia and symptoms in these patients were easily corrected with the subcutaneous administration of recombinant human erythropoietin.

Moreover, three days after subcutaneous administration of this strain, animals were also protected against septicemic or primary pneumonic plague.

However, subcutaneous administration of this cytokine at a site distant from the growing tumor did not show any antitumor effects.

When surgical intervention is contraindicated, symptomatic medical treatment should be started through continuous subcutaneous administration of analgesic and antiemetic drugs.

Moreover, recombinant L. plantarum producing increasing amounts of TTFC was used to establish a dose-response curve after subcutaneous administration to mice.

Since epoetin is expensive, optimizing the therapeutic effect of epoetin using a strategy that includes subcutaneous administration could lead to substantial cost savings.

Results: Inguinal lymph nodes, iliac lymph nodes and lymph vessels showed peak enhancement within 10 minutes after subcutaneous administration of the contrast agent.

Purpose: To investigate the enhancement of regional lymph nodes, lymph vessels and the thoracic duct after subcutaneous administration of the dendritic contrast agent Gadomer-17.

The subcutaneous administration route led to equivalent targeting results when compared with intravenous administration and was thus selected for the clinical development of the product.

Recently, we reported the first proof-of-principle study of a 17β-HSD2 inhibitor in a bone fracture mouse model, using subcutaneous administration.

Conclusions: The subcutaneous administration of octreotide in acute pancreatitis of moderate severity might be of little benefit only at a dose of 200 micrograms t.i.d.